
Sign up to save your podcasts
Or


Statin Myopathy
Guest: Stephen Kopecky, M.D.
Host: Sharonne Hayes, M.D.
Statins are very helpful to lower LDL cholesterol and subsequently lower cardiovascular risk. Studies of statins have excluded subjects that are statin intolerant which is usually due to muscle symptoms such as aches, called myalgias, muscle cramps, or weakness. One of the most significant predictors of statin intolerance is the dose -the higher the dose, the more likely to develop intolerance. Accepted in recommended ways to minimize intolerance is to use generic combination therapy with a lower dose statin and a cholesterol absorption inhibiting agent such as ezetimibe. Newer agents such as PCS K 9 inhibitors and inclisiran, both given subQ, and bempedoic acid may reduce statin muscle symptoms.
Topics Discussed:
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
No CME credit offered for this episode.
Podcast episode transcript found here.
By Mayo Clinic4.5
2929 ratings
Statin Myopathy
Guest: Stephen Kopecky, M.D.
Host: Sharonne Hayes, M.D.
Statins are very helpful to lower LDL cholesterol and subsequently lower cardiovascular risk. Studies of statins have excluded subjects that are statin intolerant which is usually due to muscle symptoms such as aches, called myalgias, muscle cramps, or weakness. One of the most significant predictors of statin intolerance is the dose -the higher the dose, the more likely to develop intolerance. Accepted in recommended ways to minimize intolerance is to use generic combination therapy with a lower dose statin and a cholesterol absorption inhibiting agent such as ezetimibe. Newer agents such as PCS K 9 inhibitors and inclisiran, both given subQ, and bempedoic acid may reduce statin muscle symptoms.
Topics Discussed:
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
No CME credit offered for this episode.
Podcast episode transcript found here.

137 Listeners

317 Listeners

498 Listeners

883 Listeners

298 Listeners

3,347 Listeners

137 Listeners

1,145 Listeners

62 Listeners

195 Listeners

515 Listeners

367 Listeners

248 Listeners

426 Listeners

370 Listeners